These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2863476)

  • 1. HTLV-III antibody in Swiss and English intravenous drug abusers.
    Mortimer PP; Vandervelde EM; Jesson WJ; Pereira MS; Burkhardt F
    Lancet; 1985 Aug; 2(8452):449-50. PubMed ID: 2863476
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibody to lymphadenopathy-associated virus/human T lymphotropic virus type III in various groups of illicit drug abusers in New York City.
    Maayan S; Backenroth R; Rieber E; Jainchill N; Yaeger A; De Leon G; Getchell JP; Miller SN; Pollack CC; Wormser GP
    J Infect Dis; 1985 Oct; 152(4):843. PubMed ID: 2995507
    [No Abstract]   [Full Text] [Related]  

  • 3. High frequency of HTLV-III antibodies among heterosexual intravenous drug abusers in the Austrian Tyrol.
    Fuchs D; Blecha HG; Deinhardt F; Dierich MP; Goebel FD; Hengster P; Hinterhuber H; Schoenitzer D; Traill K; Wachter H
    Lancet; 1985 Jun; 1(8444):1506. PubMed ID: 2861431
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevalence of antibodies to HTLV-I, -II, and -III in intravenous drug abusers from an AIDS endemic region.
    Robert-Guroff M; Weiss SH; Giron JA; Jennings AM; Ginzburg HM; Margolis IB; Blattner WA; Gallo RC
    JAMA; 1986 Jun; 255(22):3133-7. PubMed ID: 3009910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HTLV-III seropositivity in 1971-1972 parenteral drug abusers--a case of false positives or evidence of viral exposure?
    Moore JD; Cone EJ; Alexander SS
    N Engl J Med; 1986 May; 314(21):1387-8. PubMed ID: 3010112
    [No Abstract]   [Full Text] [Related]  

  • 6. HTLV-III antibody in intravenous drug abusers of metropolitan Barcelona, Spain.
    Tor J; Muga R; Argelagues E; Rey-Joly C; Foz M; Ribas-Mundó M
    Arch Intern Med; 1986 Apr; 146(4):805. PubMed ID: 3008680
    [No Abstract]   [Full Text] [Related]  

  • 7. HTLV-III antibody among Italian drug addicts.
    Ferroni P; Geroldi D; Galli C; Zanetti AR; Cargnel A
    Lancet; 1985 Jul; 2(8445):52-3. PubMed ID: 2861509
    [No Abstract]   [Full Text] [Related]  

  • 8. HTLV-III antibody in Edinburgh drug addicts.
    Peutherer JF; Edmond E; Simmonds P; Dickson JD; Bath GE
    Lancet; 1985 Nov; 2(8464):1129-30. PubMed ID: 2865601
    [No Abstract]   [Full Text] [Related]  

  • 9. HTLV-III antibodies in drug addicts in Spain.
    Rodrigo JM; Serra MA; Aguilar E; del Olmo JA; Gimeno V; Aparisi L
    Lancet; 1985 Jul; 2(8447):156-7. PubMed ID: 2862347
    [No Abstract]   [Full Text] [Related]  

  • 10. [Usefulness of the determination of anti-HTLV-III antibodies in parenteral drug addicts].
    Forteza-Rei J; Altés J; Villalonga C; Riera M
    Med Clin (Barc); 1986 Apr; 86(14):610. PubMed ID: 3014238
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prevalence of antibodies against HTLV-III in various regions in Switzerland].
    Schüpbach J; Vogt M; Bhushan R; Lüthy R; Haller O; Joller H; Ferber T; Büchner S; Schuppli R; Schädelin J
    Schweiz Med Wochenschr; 1985 Jul; 115(30):1048-54. PubMed ID: 2994208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transmission of HTLV-II.
    Chorba T
    JAMA; 1986 Dec; 256(22):3094. PubMed ID: 2878093
    [No Abstract]   [Full Text] [Related]  

  • 13. A stage model of HTLV-III LAV infection in intravenous drug users.
    Des Jarlais DC; Friedman SR; Spira TJ; Zolla-Pazner S; Marmor M; Holzman R; Mildvan D; Yancovitz S; Mathur-Wagh U; Garber J
    NIDA Res Monogr; 1986; 67():328-34. PubMed ID: 3018574
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibodies to HTLV-III in Swiss patients with AIDS and pre-AIDS and in groups at risk for AIDS.
    Schüpbach J; Haller O; Vogt M; Lüthy R; Joller H; Oelz O; Popovic M; Sarngadharan MG; Gallo RC
    N Engl J Med; 1985 Jan; 312(5):265-70. PubMed ID: 2981407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Increase in the prevalence of antibodies against LAV/HTLV III in drug addicts in West Germany].
    Zoulek G; Gürtler L; Eberle J; Lorbeer B; Deinhardt F
    Dtsch Med Wochenschr; 1986 Apr; 111(15):567-70. PubMed ID: 3007065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Laboratory results in the evaluation of anti HTLV-III in subjects at risk].
    Maschio C; Colangeli S; Rughetti A; Fonzi D; Barnabei R; Ciccarella A
    Riv Emoter Immunoematol; 1985; 32(3):302-6. PubMed ID: 3008301
    [No Abstract]   [Full Text] [Related]  

  • 17. Screening for antibody to HTLV-III in blood donors of Liguria. Ligurian Committee for the Study of Infections Transmitted through Blood and Blood Products.
    Boll Ist Sieroter Milan; 1985; 64(5):363-6. PubMed ID: 3004542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV antibodies in intravenous drug abusers.
    Wodak A; Gold J
    Med J Aust; 1986 Sep; 145(6):298. PubMed ID: 3018463
    [No Abstract]   [Full Text] [Related]  

  • 19. Sex as a risk factor for HTLV-I spread among intravenous drug abusers.
    Rezza G; Titti F; Rossi GB; Verani P; Menniti-Ippolito F; Oliva C
    Lancet; 1988 Mar; 1(8587):713. PubMed ID: 2895250
    [No Abstract]   [Full Text] [Related]  

  • 20. Intravenous drug abuse and the accident and emergency department: AIDS (HTLV-III) antibodies and hepatitis B markers.
    Dunlop MG; Steedman DJ; Peutherer JF
    Arch Emerg Med; 1986 Dec; 3(4):257-9. PubMed ID: 3026414
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.